Bank of New York Mellon’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
N
Bank of New York Mellon's GILD Position: Q2 2026 in Review
Bank of New York Mellon increased its Gilead Sciences (GILD) stake by 1.4% in Q2 2026, buying an estimated $27.8M and bringing the position to 15,263,929 shares worth $1.93B. The position accounts for 0.32% of the portfolio, ranked #52.
Bank of New York Mellon first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.29B in Q2 2015. 1,763 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Bank of New York Mellon held 15,263,929 shares of Gilead Sciences worth $1.93B as of Q2 2026.
- Bank of New York Mellon bought 210,778 Gilead Sciences shares in Q2 2026, an estimated $27.8M.
- Gilead Sciences made up 0.32% of Bank of New York Mellon's portfolio in Q2 2026, its #52 holding.
- Bank of New York Mellon first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Gilead Sciences position peaked at $3.29B in Q2 2015.
- 1,763 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.